Clinical trial
Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have…
NCT00348816 · The University of Texas Health Science Center at San Antonio, Other · Terminated
Key facts
| NCT number | NCT00348816 |
|---|---|
| Title | Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer |
| Official title | A Phase II Study to Assess the Feasibility and Activity of Concomitant Radiation and Docetaxel Chemotherapy Followed by Docetaxel Chemotherapy in Prostate Cancer Patients With a Persistent or Rising PSA After Radical Prostatectomy |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | docetaxel, prednisone, Radical prostatectomy, Radiation therapy |
| Enrollment | 21 |
| Start date | May 1, 2006 |
| Primary completion | Jul 8, 2016 |
| Completion | Jul 8, 2016 |
| First posted | Jul 6, 2006 |
| Last update posted | Dec 8, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: